325 related articles for article (PubMed ID: 26994144)
1. Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma.
Mason NJ; Gnanandarajah JS; Engiles JB; Gray F; Laughlin D; Gaurnier-Hausser A; Wallecha A; Huebner M; Paterson Y
Clin Cancer Res; 2016 Sep; 22(17):4380-90. PubMed ID: 26994144
[TBL] [Abstract][Full Text] [Related]
2. Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human.
Shahabi V; Seavey MM; Maciag PC; Rivera S; Wallecha A
Cancer Gene Ther; 2011 Jan; 18(1):53-62. PubMed ID: 20725099
[TBL] [Abstract][Full Text] [Related]
3. Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.
Wang X; Wang JP; Rao XM; Price JE; Zhou HS; Lachman LB
Breast Cancer Res; 2005; 7(5):R580-8. PubMed ID: 16168101
[TBL] [Abstract][Full Text] [Related]
4. The immunotherapy of canine osteosarcoma: a historical and systematic review.
Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(3):759-69. PubMed ID: 25929293
[TBL] [Abstract][Full Text] [Related]
5. Safety evaluation of the canine osteosarcoma vaccine, live Listeria vector.
Musser ML; Berger EP; Tripp CD; Clifford CA; Bergman PJ; Johannes CM
Vet Comp Oncol; 2021 Mar; 19(1):92-98. PubMed ID: 32729979
[TBL] [Abstract][Full Text] [Related]
6. Management of canine appendicular osteosarcoma.
Straw RC; Withrow SJ; Powers BE
Vet Clin North Am Small Anim Pract; 1990 Jul; 20(4):1141-61. PubMed ID: 2196734
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs.
LeBlanc AK; Mazcko CN; Cherukuri A; Berger EP; Kisseberth WC; Brown ME; Lana SE; Weishaar K; Flesner BK; Bryan JN; Vail DM; Burton JH; Willcox JL; Mutsaers AJ; Woods JP; Northrup NC; Saba C; Curran KM; Leeper H; Wilson-Robles H; Wustefeld-Janssens BG; Lindley S; Smith AN; Dervisis N; Klahn S; Higginbotham ML; Wouda RM; Krick E; Mahoney JA; London CA; Barber LG; Balkman CE; McCleary-Wheeler AL; Suter SE; Martin O; Borgatti A; Burgess K; Childress MO; Fidel JL; Allstadt SD; Gustafson DL; Selmic LE; Khanna C; Fan TM
Clin Cancer Res; 2021 Jun; 27(11):3005-3016. PubMed ID: 33753454
[TBL] [Abstract][Full Text] [Related]
8. A Therapeutic Her2/neu Vaccine Targeting Dendritic Cells Preferentially Inhibits the Growth of Low Her2/neu-Expressing Tumor in HLA-A2 Transgenic Mice.
Tran T; Diniz MO; Dransart E; Gey A; Merillon N; Lone YC; Godefroy S; Sibley C; Ferreira LC; Medioni J; Oudard S; Johannes L; Tartour E
Clin Cancer Res; 2016 Aug; 22(16):4133-44. PubMed ID: 27006496
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.
Eralp Y; Wang X; Wang JP; Maughan MF; Polo JM; Lachman LB
Breast Cancer Res; 2004; 6(4):R275-83. PubMed ID: 15217493
[TBL] [Abstract][Full Text] [Related]
10. Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer.
Hannan R; Zhang H; Wallecha A; Singh R; Liu L; Cohen P; Alfieri A; Rothman J; Guha C
Cancer Immunol Immunother; 2012 Dec; 61(12):2227-38. PubMed ID: 22644735
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
[TBL] [Abstract][Full Text] [Related]
12. A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors.
Seavey MM; Pan ZK; Maciag PC; Wallecha A; Rivera S; Paterson Y; Shahabi V
Clin Cancer Res; 2009 Feb; 15(3):924-32. PubMed ID: 19188163
[TBL] [Abstract][Full Text] [Related]
13. Comparative Immunology and Immunotherapy of Canine Osteosarcoma.
Mason NJ
Adv Exp Med Biol; 2020; 1258():199-221. PubMed ID: 32767244
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma: 90 cases (1997-2008).
Culp WT; Olea-Popelka F; Sefton J; Aldridge CF; Withrow SJ; Lafferty MH; Rebhun RB; Kent MS; Ehrhart N
J Am Vet Med Assoc; 2014 Nov; 245(10):1141-6. PubMed ID: 25356715
[TBL] [Abstract][Full Text] [Related]
15. Autologous cancer cell vaccination, adoptive T-cell transfer, and interleukin-2 administration results in long-term survival for companion dogs with osteosarcoma.
Flesner BK; Wood GW; Gayheart-Walsten P; Sonderegger FL; Henry CJ; Tate DJ; Bechtel SM; Donnelly LL; Johnson GC; Kim DY; Wahaus TA; Bryan JN; Reyes N
J Vet Intern Med; 2020 Sep; 34(5):2056-2067. PubMed ID: 32649801
[TBL] [Abstract][Full Text] [Related]
16. Treatment of canine appendicular osteosarcoma using cobalt 60 radiation and intraarterial cisplatin.
Heidner GL; Page RL; McEntee MC; Dodge RK; Thrall DE
J Vet Intern Med; 1991; 5(6):313-6. PubMed ID: 1779423
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2
Lowenfeld L; Mick R; Datta J; Xu S; Fitzpatrick E; Fisher CS; Fox KR; DeMichele A; Zhang PJ; Weinstein SP; Roses RE; Czerniecki BJ
Clin Cancer Res; 2017 Jun; 23(12):2961-2971. PubMed ID: 27965306
[No Abstract] [Full Text] [Related]
18. Vaccine strain Listeria monocytogenes abscess in a dog: a case report.
Musser ML; Berger EP; Parsons C; Kathariou S; Johannes CM
BMC Vet Res; 2019 Dec; 15(1):467. PubMed ID: 31864375
[TBL] [Abstract][Full Text] [Related]
19. Murine pneumotropic virus chimeric Her2/neu virus-like particles as prophylactic and therapeutic vaccines against Her2/neu expressing tumors.
Andreasson K; Tegerstedt K; Eriksson M; Curcio C; Cavallo F; Forni G; Dalianis T; Ramqvist T
Int J Cancer; 2009 Jan; 124(1):150-6. PubMed ID: 18839427
[TBL] [Abstract][Full Text] [Related]
20. Histologic Grade Does Not Predict Outcome in Dogs with Appendicular Osteosarcoma Receiving the Standard of Care.
Schott CR; Tatiersky LJ; Foster RA; Wood GA
Vet Pathol; 2018 Mar; 55(2):202-211. PubMed ID: 29284372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
